Engflag

Selsun 2.5%

Quick links to important sections

Selsun 2.5%

Selsun 2_5__ES

Method of action: Antioxidant, Antiseborrheic, Other Dermatological Preparations

Treatment option: Dermatitis

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Selsun 2.5%

Property Description
Active ingredient Selenium Sulfide (Selenium disulfide)
Concentration 2.5%
Form Suspension (Topical)
Pharmacological class Antiseborrheic and Antifungal Agent
Origin Synthetic compound
General purpose Relief of scaling, flaking, and itching

What Type of Medicine is Selsun 2.5% and What is its Composition?

Selsun 2.5% is a dermatological medicine classified as a single active ingredient product formulated as a Suspension for Topical application. Its defining component is the active ingredient Selenium Sulfide (also known as Selenium disulfide), which is present at a 2.5% concentration.

This preparation is a synthetic compound designed for localized use on the skin or scalp. The medicine is provided in an aqueous vehicle that creates a Suspension, ensuring the active ingredient adheres effectively to the target area when applied. The 2.5% concentration establishes it as a highly potent treatment, often regulated as a prescription-strength product in certain jurisdictions, differentiating it from lower-concentration, over-the-counter formulations.

Selsun 2.5% Pharmacological Class: Antiseborrheic and Antifungal Agent

The Selenium Sulfide in Selsun 2.5% is formally classified as an Antiseborrheic Agent and an Antifungal Agent due to its established dual functional properties. The compound is widely recognized for its ability to control the growth of various fungi and to address skin scaling issues.

As an Antiseborrheic Agent, it exerts a Cytostatic action by helping to slow down the rate at which new cells are produced and shed from the outer layer of the skin. This specific Cytostatic activity is a key mechanism against conditions characterized by rapid cell turnover. Simultaneously, as an Antifungal Agent, it possesses the ability to disrupt the growth of yeast and fungi, specifically the Malassezia species often found on the scalp. Selenium Sulfide is utilized as a topical treatment for addressing symptoms associated with fungal overgrowth.

What is the General Purpose and Benefit of Selsun 2.5%?

The general purpose of Selsun 2.5% is to relieve flaking, scaling, and itching caused by accelerated skin cell shedding and fungal activity. A typical use scenario involves its application to manage intense or persistent flaking on the scalp. The primary benefit is the restoration of a more normal and balanced state to the scalp surface, achieved by moderating cell turnover and controlling yeast populations. This topical treatment is specifically designed to manage the underlying physiological processes that lead to noticeable scaling and discomfort.

Regulatory References

  1. NIH DailyMed Monograph on Selenium Sulfide
  2. Selenium Sulfide Drug Information (MedlinePlus)

What side effects are possible with Selsun 2.5%?

Possible Side Effects and Safety Information

The safety profile for Selsun 2.5% (Selenium Sulfide) is structurally defined by its topical application, with adverse reactions predominantly classified under Skin and Subcutaneous Tissue Disorders in regulatory documents. This section describes the officially documented risks and safety constraints based on governmental health authority labeling.

Official Adverse Reaction Categories

Classification Documented Reactions
Common (Localized) Scalp irritation, localized burning sensation, increased dryness or oiliness of the hair or scalp, temporary increased hair loss.
Common (Hair Appearance) Hair discoloration, often noted in light-colored, gray, or chemically treated hair.
Uncommon/Rare Hypersensitivity reactions, such as rash or hives (urticaria).

Serious Safety Considerations

A potential for systemic toxicity is documented as a rare but serious consequence, primarily when the medicine is accidentally ingested or applied to highly inflamed or broken skin areas that may allow for increased absorption of the active ingredient. For this reason, official labeling contraindicates its use in cases of known hypersensitivity to Selenium Sulfide and restricts application to compromised skin.

Population-Specific Constraints

Regulatory documentation includes specific constraints for certain populations. The safety and effectiveness of the 2.5% suspension are generally not established for use in children under the age of two years. For pregnant or lactating individuals, the medicine should be used only if the potential benefit clearly justifies any potential risk, reflecting a lack of adequate, well-controlled human studies. Local irritation is often noted as a pattern that may appear at the initiation of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for Selenium Sulfide 2.5% Topical Suspension define the primary risk as accidental acute oral ingestion. In the event of an overdose, the regulator mandates that the individual must seek professional assistance or contact a Poison Control Center immediately for guidance. For management following ingestion, the consideration of evacuation of the stomach contents is the procedural step described in the official label.

The regulatory information notes that no documented reports of serious toxicity in humans have been established from acute ingestion of the topical suspension. Nevertheless, the possibility of potential human toxicity is suggested, based on data derived from animal studies involving the active ingredient. There is no specific antidote known for the active ingredient.

A significant concern also extends to topical misuse. The risk of systemic absorption is increased if the product is applied to areas of broken skin, inflamed areas, or areas with exudation. This increased absorption may lead to systemic effects. Therefore, immediate medical help is required in the case of accidental oral overdose or if potential signs of toxicity are observed following topical use on compromised skin.

Therapeutic Uses of Selsun 2.5%

What Selsun 2.5% Treats: Main Uses and Benefits

Selsun 2.5% provides targeted therapeutic support across dermatological domains characterized by specific scalp and skin disruptions, focusing exclusively on symptom management and relief. The preparation is relevant for easing symptoms associated with several common conditions.

The medication is commonly used to help manage excessive scalp scaling and flaking in conditions like pronounced Pityriasis Capitis (dandruff) and chronic seborrheic dermatitis, and is also applied to address the fungal pathogenesis of Tinea Versicolor. The suspension is relevant in contexts where additional symptomatic support is needed to address symptom clusters that may become intense or disruptive, such as itching (pruritus) and irritation. This application provides supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Persistent Scaling and Irritative States

Relief of Chronic Symptom Patterns

In cases of recurrent or chronic conditions, Selsun 2.5% is applied during phases when symptoms become more noticeable. By moderating these distressing manifestations, the medicine supports general comfort during symptomatic periods and may assist in easing the impact of symptoms during difficult episodes. This is applicable when conditions produce significant symptomatic burden and short-term symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Population Eligibility for Selsun 2.5%

The official regulatory profile for Selsun 2.5% (Selenium Sulfide Topical Suspension) defines eligibility based on a few critical restrictions, strictly limiting its use to specific populations as documented in government labeling (e.g., FDA, EMA).

Contraindicated Populations and Conditions

Category Regulatory Restriction
Hypersensitivity Status Contraindicated in individuals with a known or suspected allergy to selenium sulfide or any product ingredient.
Skin Condition Restricted from use on broken skin, inflamed areas, or where acute inflammation or exudation is present, due to the risk of increased systemic absorption.

Age-Based and Conditional Restrictions

Age Restrictions: The safety and effectiveness of Selsun 2.5% have not been established in infants and in children under 12 years of age; therefore, use is limited or not recommended in these populations.

Pregnancy and Lactation: For pregnant women being treated for Tinea Versicolor, the product is classified as Pregnancy Category C by the FDA, and use is generally not recommended. Nursing mothers should exercise caution, as it is not known whether the drug is secreted in human milk.

Use is generally permitted for adults and adolescents who meet all non-contraindication criteria.

What should I know about interactions with other medicines?

The active ingredient in Selsun 2.5%, Selenium Sulfide, is administered as a topical suspension, a route that results in minimal systemic absorption into the bloodstream. Due to this limited uptake, the official regulatory profile for this medicine is characterized by a significant absence of documented systemic interactions with other medicinal products, foods, or substances.

Absence of Systemic Interactions

The regulatory labeling does not list any specific drug-drug combinations that are formally contraindicated based on pharmacological interactions. Furthermore, official documents confirm that there are no documented interactions involving major metabolic pathways, such as the cytochrome P450 (CYP450) enzymes, or drug transporter systems. This also extends to no documented warnings regarding interactions with food, alcohol, or herbal supplements in the official prescribing information.

Condition-Dependent Exposure Constraint

The singular interaction-related constraint noted in regulatory sources is tied to the integrity of the skin barrier. Application of the suspension to areas with acute inflammation or exudation (broken or oozing skin) may lead to increased systemic absorption of the active ingredient. This condition represents the only officially documented factor that potentially alters the pharmacological exposure profile of Selsun 2.5%, and the restriction is in place to mitigate the risk associated with this increased uptake.

Mechanism of Action

The mechanism of action for Selenium Sulfide is defined by its dual influence on two distinct biological processes: the mitotic activity of skin cells and the proliferation of surface fungi. These combined actions modulate the physiological processes involving epidermal cell proliferation and microbial density.

Cytostatic Action: Normalizing Epidermal Cell Turnover

This domain covers the action on epidermal epithelial cells where the active ingredient acts as a cytostatic inhibitor. The mechanism involves interfering with DNA synthesis in the basal layer, which decreases the rate of cell division (mitosis). This targeted modulation of the cell cycle contributes to a decrease in the frequency of cell shedding, which reduces the proliferation and aggregation of epidermal cells.

Antifungal Action: Suppression of Malassezia Proliferation

This domain addresses the drug’s inhibitory effect on Malassezia yeast species on the skin surface. The mechanism involves disrupting the fungi’s cellular growth and metabolic processes, thereby reducing their population density. This suppression of microbial proliferation leads to a decrease in the yeast's capacity to produce irritating free fatty acids from natural skin oils, resulting in diminished chemical irritant activity at the application site.

Dosage and Administration Information

Administration Scope

The administration of Selsun 2.5% Suspension is characterized by specific parameters regarding indication, application quantity, contact time, and frequency, used via the Topical route for external use only. The suspension must be shaken well before using to ensure uniform composition.

Dosing Regimens

The dosage and schedule vary based on the condition being addressed. The application quantity for the scalp is generally 1 or 2 teaspoonfuls of the suspension.

Condition Initial Dosing Frequency & Duration Contact Time Maintenance Schedule
Seborrheic Dermatitis/Dandruff Twice a week for two weeks 2 to 3 minutes on scalp Used at less frequent intervals (e.g., weekly, every 2-4 weeks) to maintain control
Tinea Versicolor Once a day for seven days 10 minutes on skin Not applicable (short-term course)

Procedural Conditions and Population Rules

After application, the treated area must be rinsed thoroughly with water. For the maintenance of chemically treated hair, such as bleached or tinted hair, prolonged rinsing (e.g., for at least 5 minutes) is required to minimize the potential for discoloration.

Metallic jewelry must be removed prior to use as the preparation may cause discoloration.

The regimen for children aged 5 to 14 years with dandruff or seborrheic dermatitis is typically the same as for adults, but use in children under 5 years is not established.

Recent Clinical Evidence

The research evidence for Selsun 2.5% (Selenium Sulfide) involves studies for two primary indications: Pityriasis Capitis (Dandruff) and Seborrheic Dermatitis of the Scalp, and the fungal skin condition Tinea Versicolor.

For scalp conditions, research has examined the product in settings involving adults with moderate to severe symptoms. The evidence primarily comes from short-term Randomized Controlled Trials (RCTs) and comparative studies, typically lasting around four weeks. Researchers monitored changes in scalp scaling and flaking scores (clinical grading scales) and patient-reported outcomes describing perceived discomfort, such as changes in itching (pruritus). Findings indicate patterns regarding these measured outcomes in the observed populations during the initial treatment interval.

Research has also explored the product for Tinea Versicolor using short-course treatment durations. Studies monitored outcomes related to mycological clearance (elimination of fungal presence, tracked by laboratory tests) and clinical response.

A key research limitation across both indications is that the available evidence is often short-term, meaning long-term effects are not fully established, and there is limited information regarding the durability of the response or optimal maintenance frequency. The core evidence is focused on adults, and data for certain groups, such as children (under 12 years), remain insufficient or are subject to regulatory restrictions. The overall evidence quality varies across studies, and a limited number of large-scale, long-term comparative RCTs are available in the current literature. The research provides context but also describes what is known—and what is still uncertain.

How should Selsun 2.5% be stored and disposed of?

Official Storage and Disposal Requirements

Selsun 2.5% (selenium sulfide topical suspension) must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with protection from temperature extremes. The product must be protected from freezing and excessive heat.

Storage Requirement Official Condition
Temperature Range 20 C to 25 C (Controlled Room Temperature)
Container Rule Keep bottle tightly closed or tightly capped
Child Safety Keep out of the reach of children
Stability Note May darken upon storage, which does not impair efficacy

Disposal instructions in regulatory labeling primarily address handling in case of accidental oral ingestion, requiring immediate contact with a Poison Control Center. Unused or expired medication should be disposed of according to local/national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagFrance

flagUnited Kingdom

Equivalent of Selsun 2.5% found in:

A-Z Index: